infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: In long-acting GnRH-a group (group I), half-dose ( 1.87 mg ) of Triptuneline (Diphereline® S.R. 3.75mg) is administrated in a single intramuscular injection in m
Sponsors
Deputy of Research and Technology, Yazd Shahid Sadoughi Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 38 Years
Inclusion criteria
Inclusion criteria: Age between 18-38 years History of infertility at least for 1 year FSH concentration in day 3 of menstrual cycle <12 mIU/ml.
Exclusion criteria
Exclusion criteria: History of pelvic surgery Abnormal thyroid function Endocrinopathies Severe male factor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 7 weeks after embryo transfer. Method of measurement: Detecting fetal heart rate in sonography.;Implantation rate. Timepoint: 7 weeks after embryo transfer. Method of measurement: The number of gestational sac divided by the number of transferred embryos. | — |
Secondary
| Measure | Time frame |
|---|---|
| No of used gonadotropin ampuls. Timepoint: 2 weeks. Method of measurement: count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Reaserch and clinical center for infertility
Outcome results
None listed